Salvinorin A: a potent naturally occurring nonnitrogenous kappa opioid selective agonist (Q24535736)

5 July 2017

title

Salvinorin A: a potent naturally occurring nonnitrogenous kappa opioid selective agonist (English)

1 reference

5 July 2017

0 references

Paul Ernsberger

7

0 references

Richard B. Rothman

8

object named as

Richard B Rothman

1 reference

5 July 2017

Bryan L Roth

1

1 reference

5 July 2017

Karen Baner

2

1 reference

5 July 2017

Richard Westkaemper

3

1 reference

5 July 2017

Daniel Siebert

4

1 reference

5 July 2017

Kenner C Rice

5

1 reference

5 July 2017

SeAnna Steinberg

6

1 reference

5 July 2017

language of work or name

English

0 references

publication date

21 August 2002

1 reference

5 July 2017

number of pages

6

1 reference

Proceedings of the National Academy of Sciences of the United States of America

inferred from page(s)

published in

1 reference

5 July 2017

volume

99

1 reference

5 July 2017

issue

18

1 reference

5 July 2017

page(s)

11934-11939

1 reference

Dynorphin-(1-13), an extraordinarily potent opioid peptide

5 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=129372

Crystal structure of rhodopsin: A G protein-coupled receptor

24 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=129372

Enadoline, a selective kappa opioid agonist: comparison with butorphanol and hydromorphone in humans

24 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=129372

Evidence for possible involvement of 5-HT(2B) receptors in the cardiac valvulopathy associated with fenfluramine and other serotonergic medications

24 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=129372

2-Substituted tryptamines: agents with selectivity for 5-HT(6) serotonin receptors

24 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=129372

Psychotomimesis mediated by kappa opiate receptors

24 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=129372

The effects of morphine- and nalorphine- like drugs in the nondependent and morphine-dependent chronic spinal dog

24 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=129372

Salvinorin C, a new neoclerodane diterpene from a bioactive fraction of the hallucinogenic Mexican mint Salvia divinorum

24 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=129372

Exploring the relationship between binding modes of 9-(aminomethyl)-9,10-dihydroanthracene and cyproheptadine analogues at the 5-HT2A serotonin receptor

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=129372

Mu-, delta- and kappa-opioid receptor populations are differentially altered in distinct areas of postmortem brains of Alzheimer's disease patients

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=129372

Salvia divinorum: an hallucinogenic mint which might become a new recreational drug in Switzerland.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=129372

Modeling of kappa-opioid receptor/agonists interactions using pharmacophore-based and docking simulations

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=129372

An open-label study of a functional opioid kappa antagonist in the treatment of opioid dependence

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=129372

Opioid receptor three-dimensional structures from distance geometry calculations with hydrogen bonding constraints

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=129372

Primary structure and functional expression of a guinea pig kappa opioid (dynorphin) receptor

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=129372

A single point mutation increases the affinity of serotonin 5-HT1D alpha, 5-HT1D beta, 5-HT1E and 5-HT1F receptors for beta-adrenergic antagonists

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=129372

Salvia divinorum and the unique diterpene hallucinogen, Salvinorin (divinorin) A.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=129372

Salvia divinorum and salvinorin A: new pharmacologic findings

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=129372

Evidence for 5-HT2 involvement in the mechanism of action of hallucinogenic agents

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=129372

Novel opiate binding sites selective for benzomorphan drugs

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=129372

Characterization of the kappa-subtype of the opiate receptor in the guinea-pig brain

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=129372

Relative contents and concomitant release of prodynorphin/neoendorphin-derived peptides in rat hippocampus

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=129372

Dynorphin is contained within hippocampal mossy fibers: immunochemical alterations after kainic acid administration and colchicine-induced neurotoxicity

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=129372

History and development of mixed opioid agonists, partial agonists and antagonists

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=129372

5-Hydroxytryptamine2A (5-HT2A) receptor desensitization can occur without down-regulation

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=129372

The therapeutic role of naltrexone in negative symptom schizophrenia.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=129372

The distribution and morphology of opioid peptide immunoreactive neurons in the cerebral cortex of rats

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=129372

Dynorphin Is a Specific Endogenous Ligand of the κ Opioid Receptor

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=129372

Tritiated etorphine and naloxone binding to opioid receptors in caudate nucleus in schizophrenia

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=129372

Differential ontogeny of multiple opioid receptors (mu, delta, and kappa).

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=129372

Divinorin A, a psychotropic terpenoid, and divinorin B from the hallucinogenic Mexican mint, Salvia divinorum

30 May 2018

1 reference

https://api.crossref.org/works/10.1073/PNAS.182234399

Synthesis, opioid receptor binding, and biological activities of naltrexone-derived pyrido- and pyrimidomorphinans

21 January 2018

1 reference

https://api.crossref.org/works/10.1073/PNAS.182234399

Differences in G-protein activation by mu- and delta-opioid, and cannabinoid, receptors in rat striatum

21 January 2018

1 reference

https://api.crossref.org/works/10.1073/PNAS.182234399

N-substituted octahydro-4a-(3-hydroxyphenyl)-10a-methyl-benzo[g]isoquinolines are opioid receptor pure antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1073/PNAS.182234399

Evidence for a model of agonist-induced activation of 5-hydroxytryptamine 2A serotonin receptors that involves the disruption of a strong ionic interaction between helices 3 and 6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1073/PNAS.182234399

Ontogeny of benzomorphan-selective (κ) sites: A computerized analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1073/PNAS.182234399

Prodynorphin and kappa opioid receptor mRNA expression in the cingulate and prefrontal cortices of subjects diagnosed with schizophrenia or affective disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1073/PNAS.182234399

Characterization of kappa1-opioid receptor binding in human insular cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1073/PNAS.182234399

Opioid receptor density changes in Alzheimer amygdala and putamen

21 January 2018

1 reference

https://api.crossref.org/works/10.1073/PNAS.182234399

Cell-type specific effects of endocytosis inhibitors on 5-hydroxytryptamine(2A) receptor desensitization and resensitization reveal an arrestin-, GRK2-, and GRK5-independent mode of regulation in human embryonic kidney 293 cells

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=129372

Differential ergoline and ergopeptine binding to 5-hydroxytryptamine2A receptors: ergolines require an aromatic residue at position 340 for high affinity binding

29 November 2018

1 reference

12 December 2020

Identification of conserved aromatic residues essential for agonist binding and second messenger production at 5-hydroxytryptamine2A receptors

1 reference

12 December 2020

Naltrexone augmentation of neuroleptics in schizophrenia

1 reference

12 December 2020

5-Hydroxytryptamine2-family receptors (5-hydroxytryptamine2A, 5-hydroxytryptamine2B, 5-hydroxytryptamine2C): where structure meets function

1 reference

12 December 2020

Identifiers

DOI

10.1073/PNAS.182234399

1 reference

OpenCitations bibliographic resource ID

5 July 2017

0 references

3304855

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

1 reference

5 July 2017

1 reference